Add BrightSurf on Google Email

The Lancet


BCG vaccine effect against tuberculosis infection and disease

Researchers investigated risk factors for TB infection in 979 children from Istanbul, Turkey. They found that the absence of a BCG scar was a strong, independent risk factor for infection, while its presence reduced the risk by 24%. The study suggests that BCG vaccination also protects against TB infection, opening new avenues for deve...

SourceThe Lancet_DELETED·JournalThe Lancet·DateOct 12, 2005

New treatment option for childhood cholera

A new single-dose ciprofloxacin treatment has been shown to be effective in treating childhood cholera, with 60% of cases cured within 48 hours. However, the new treatment is less effective at eradicating the cholera bacteria from stool compared to a 12-dose course of erythromycin.

SourceThe Lancet_DELETED·JournalThe Lancet·DateSep 13, 2005

Drug can reduce hot flashes for women with breast cancer

A new study by Kishan Pandya and colleagues found that gabapentin significantly reduced hot flash severity scores in women with breast cancer. The results suggest that gabapentin can be added to the list of non-hormonal agents for controlling hot flashes in these patients, with further studies needed on higher doses.

SourceThe Lancet_DELETED·JournalThe Lancet·DateSep 1, 2005

Toxicity predicts effective chemotherapy dose

Research finds that neutropenia, a type of hematological toxicity, is associated with increased overall survival in patients with advanced non-small cell lung cancer. Prospective trials are needed to assess whether drug dosing guided by toxic effects could improve chemotherapy efficacy.

SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateAug 30, 2005

Sleeping sickness epidemic spreading in Uganda

A study found that mass treatment interventions in Uganda had no significant impact on reducing the prevalence of human infective T b rhodesiense parasites. Since 1998, over 428 new cases have been diagnosed in the Sorotic district, with an additional 300 cases likely going undiagnosed.

SourceThe Lancet_DELETED·JournalThe Lancet·DateAug 25, 2005

Obese women undertreated for breast cancer

A recent study has found that obese patients with estrogen-receptor negative (ER-negative) breast cancer are at risk of undertreatment due to reduced chemotherapy doses. The study, published in The Lancet, suggests that obese women with ER-negative disease who receive 85% or more of the recommended first course dose have significantly ...

SourceThe Lancet_DELETED·JournalThe Lancet·DateAug 23, 2005

New approach has potential to treat latent HIV infection

A new approach using valproic acid has shown promise in reducing latent HIV infection by 75% in three out of four patients. The researchers suggest that a staged treatment process, starting with standard antiretroviral regimens and then targeting latent viral infection with HDAC inhibitors, could lead to the cure of HIV.

SourceThe Lancet_DELETED·JournalThe Lancet·DateAug 11, 2005